Genenta Science SPA banner

Intrinsic Value

Not Available for SAEN

There is not enough data to reliably calculate the intrinsic value for Genenta Science SPA.

Do our valuations actually work? See backtest results .

Alternatives to SAEN

Fundamental Analysis

What Genenta Science SPA Does

Biotechnology Health Care

Genenta Science is a biotechnology company that develops gene therapy treatments for cancer. Its main idea is to take a patient’s blood-forming stem cells, modify them in the lab, and use them to deliver anti-tumor signals inside the body. The company’s lead work is centered on Temferon, a platform designed to help the immune system attack solid tumors from within the tumor environment.

Headquarters
Italy IT
Employees
9
IPO date
Dec 15, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Genenta Science SPA

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue SAEN Research

Decided on Genenta Science? Get an email when SAEN reaches the price you’d buy at. Free with an account.

Other Genenta Science listings

Back to Top